Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Johnson & Johnson
 More »

  • J&J Innovation, Janssen, and Joslin Diabetes to Pump Up Exercise...
    Joslin Diabetes Center is teaming up with Johnson & Johnson Innovation and its affiliate Janssen Research & Development with the aim of identifing and advancing early-stage, novel ...
    10-10-2013
  • J&J's Janssen Buys Rights to Hepatitis C Compound from GSK
    Johnson & Johnson's Janssen Pharmaceuticals unit said today it acquired GSK2336805, an investigational once-daily NS5a replication complex inhibitor for chronic hepatitis C, from ...
    10-8-2013
  • Eppendorf Sponsoring Shared Lab Space at Cambridge, MA
    LabCentral received a $5 million grant from the Massachusetts Life Science Center in February of 2013. Triumvirate Environmental and Johnson & Johnson Innovation became founding ...
    10-4-2013
  • J&J's Janssen Companies Launch a Trio of Collaborations
    The Janssen Pharmaceutical Companies of Johnson & Johnson had itself a very busy day yesterday, with two of its sister companies involved in three research and drug development ...
    10-3-2013
  • FDA Speeds Things Up
    ... for metastatic breast cancer; Novartis' LDK378 for ALK-positive lung cancer; and Johnson & Johnson's/Pharmacylics' ibrutinib (PCI-32765) for various types of leukemia and ...
    10-1-2013
  • Takeover Targets: Who Is First on the List?
    ... By year's end, Medivation expected to release promising additional data on Xtandi for prechemo CRPC, and eventually compete head on with Johnson & Johnson mCPRC drug Zytiga. August ...
    9-24-2013
  • Top 40 Molecular Millionaires
    ... 8 45 Closing price on March 8: $61.94 #14. William C. Weldon Retired Chairman, Johnson & Johnson 46 Total value of all shares: $260,500,765 47 386,591 shares of common stock 48 ; ...
    9-19-2013
  • Dendreon Gets Green Light in Europe
    million in sales during 2013. Sales have struggled because of competition from prostate cancer drugs by Johnson & Johnson and Medivation, as well as Provenge's $93,000 price tag. ...
    9-17-2013
  • Researchers Chafe as NIH Budgets Shrivel
    ... Mental Health Research Organization-Johnson & Johnson Rising Star Translational Research Award, and two U.S. Office of Naval Research grants (N00014-09-1-059 and N00014-12-1-0366). ...
    9-11-2013
  • FDA Speeds Things Up
    ... for metastatic breast cancer; Novartis' LDK378 for ALK-positive lung cancer; and Johnson & Johnson's/Pharmacylics' ibrutinib (PCI-32765) for various types of leukemia and ...
    9-3-2013
  • AAV Vectors for Infectious Diseases
    A few years back, the Bill & Melinda Gates Foundation approached the Gene Therapy Program ... antibodies against HIV. Philip R. Johnson, M.D., a professor at The Children's ...
    9-1-2013
  • Top Biotech & Pharma Companies
    Earlier this year, Burrill pointed out that Big Biotech firms (e.g., Amgen, Gilead Sciences, Regeneron Pharmaceuticals, and Biogen Idec) have outpaced Big Pharma (e.g., Johnson & ...
    9-1-2013
  • Spreading Sunshine on What Biopharma Pays Physicians
    ... Pharmaceutical Industries), Eli Lilly, Novartis, Merck & Co., two divisions of Johnson & Johnson, and subsidiaries of Forest Laboratories, Merck KGaA, and UCB are among pharmas ...
    8-29-2013
  • Executive VP at AbbVie Tops GEN List as Highest Paid Woman in...
    For example, numbers one and two on that list were Leonard Schleifer of Regeneron (NASDAQ:REGN) with $30,047,097 in 2012 and William Weldon, formerly of Johnson & Johnson ...
    8-14-2013
  • Amunix, Janssen Expand XTEN Collaboration
    Amunix Operating said today its eight-month-old research collaboration and licensing agreement with Johnson & Johnson's Janssen Biotech unit will expand now that an option has been ...
    8-14-2013
  • More »

    Journal Articles

  • Johnson & Johnson: The Credo-Driven Product Stewardship Leader

    Sustainability: The Journal of Record
    Johnson & Johnson: The Credo-Driven Product Stewardship Leader Sustainability: The Journal of Record
  • Atypical Stevens-Johnson Syndrome in an Adolescent Treated with...
    Jeffrey R. Strawn, Rachel Whitsel, Jayasree J. Nandagopal, Melissa P. DelBello
    Journal of Child and Adolescent Psychopharmacology
    Atypical Stevens-Johnson Syndrome in an Adolescent Treated with Duloxetine Journal of Child and Adolescent Psychopharmacology
  • Acute Interstitial Nephritis and Fatal Stevens-Johnson Syndrome...
    A. Dysseleer, M. Buysschaert, C. Fonck, K. Van Ginder Deuren, M. Jadoul, D. Tennstedt, J. P. Cosyns, Ch. Daumerie
    Thyroid
    Acute Interstitial Nephritis and Fatal Stevens-Johnson Syndrome after Propylthiouracil Therapy Thyroid We report a case of acute interstitial nephritis and fatal Stevens-Johnson ...
  • The Robert Wood Johnson Foundation Grant-making Strategies to...
    Rosemary Gibson
    Journal of Palliative Medicine
    The Robert Wood Johnson Foundation Grant-making Strategies to Improve Care at the End of Life Journal of Palliative Medicine

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll